TRCT
LIMN

Tower Research Capital (TRC)’s Liminatus Pharma, Inc. Class A Common Stock LIMN Stock Holding History

Tower Research Capital (TRC)’s Portfolio LIMN Stock Details LIMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$5.66K Buy
+508
New +$5.66K ﹤0.01% 4160